The pharmaceutical landscape is experiencing a change with the arrival of GLP-1 transdermal systems . These cutting-edge formulations offer a potential approach to administering glucagon-like peptide-1 drugs for individuals living with hyperglycemia. Instead of needles, a convenient patch placed